USE OF RITUXIMAB IN AUTOIMMUNE DISEASES: NEW ASPECTS
It has been noted that off-label indication for Rituximab (RTX) in rheumatological care indubitably requires its confirmation in the randomized clinical trials.A particular cautious approach should be taken in extending the indications for therapy with gene-engineering biologicals because Omegas of the intricacy and interaction of different immunor